Apimostinel
id:
apimostinel-258-3571682
title:
Apimostinel
text:
Apimostinel is an investigational antidepressant, acting as a novel and selective modulator of the NMDA receptor. It is currently under development for the acute treatment of major depressive disorder (MDD) by Gate Neurosciences, and previously by Naurex and Allergan. As of February 2015, an intravenous formulation of apimostinel has completed a phase IIa clinical trial for MDD. Similar to rapastinel (GLYX-13), its mechanism of action acts through a unique binding site on the NMDA receptor, inde
brand slug:
wiki
category slug:
encyclopedia
description:
Investigational antidepressant compound
original url:
https://en.wikipedia.org/wiki/Apimostinel
date created:
date modified:
2024-01-25T19:08:52Z
main entity:
{"identifier":"Q27290341","url":"https://www.wikidata.org/entity/Q27290341"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/f4/NRX-1074.svg","width":512,"height":324}
fields total:
13
integrity:
15